{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:11:10Z","timestamp":1774984270661,"version":"3.50.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T00:00:00Z","timestamp":1628467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The risk of amyloidosis during the course of AS is yet to be firmly established. We aimed to evaluate the risks, predictors and prognostic outcomes of amyloidosis among patients with AS.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A population-based cohort study was conducted comparing AS patients (n\u2009=\u20095911) with age-, sex- and ethnicity-matched control subjects (n\u2009=\u200929 007) with regard to incident cases of amyloidosis. Hazard ratios (HRs) and odds ratios (ORs) were estimated by Cox regression and logistic regression analyses, respectively.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The incidence rate of amyloidosis was 2.15 (95% CI 1.09, 2.82) and 0.35 (95% CI 0.16, 0.66) per 10 000 person-years among patients with AS and controls, respectively. The risk of incident amyloidosis was &amp;gt;6-fold higher among patients with AS relative to control subjects [adjusted HR 6.16 (95% CI 2.43, 15.62); P\u2009&amp;lt;\u20090.001]. A higher comorbidity burden [OR 1.36 (95% CI 1.08, 1.73); P\u2009=\u20090.010] was found to predict an increased susceptibility to amyloidosis in AS patients. Compared with other patients with AS, those with AS and comorbid amyloidosis had a 14-fold increased risk of end-stage renal disease necessitating dialysis [adjusted HR 14.7 (95% CI 2.0, 107.2); P\u2009=\u20090.008], but comparable risk of all-cause mortality [adjusted HR 2.16 (95% CI 0.69, 6.71); P\u2009=\u20090.174].<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Patients with AS are at an increased risk of amyloidosis. AS-associated amyloidosis is associated with an elevated risk of dialysis dependence. Awareness of the burden and consequences of this complication may be of help for rheumatologists managing patients with AS.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keab633","type":"journal-article","created":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T05:28:10Z","timestamp":1628314090000},"page":"2072-2078","source":"Crossref","is-referenced-by-count":6,"title":["The risk, predictors and outcomes of amyloidosis in ankylosing spondylitis: a longitudinal population-based cohort study"],"prefix":"10.1093","volume":"61","author":[{"given":"Mouhammad","family":"Kridin","sequence":"first","affiliation":[{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9971-9151","authenticated-orcid":false,"given":"Khalaf","family":"Kridin","sequence":"additional","affiliation":[{"name":"L\u00fcbeck Institute of Experimental Dermatology, University of L\u00fcbeck, L\u00fcbeck, Germany"},{"name":"Unit of Dermatology and Skin Research Laboratory, Baruch Padeh Poria Medical Center"},{"name":"Azrieli Faculty of Medicine, Bar-Ilan University, Safed"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnon D","family":"Cohen","sequence":"additional","affiliation":[{"name":"Department of Quality Measurements and Research, Clalit Health Services, Tel-Aviv"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard","family":"Amital","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel"},{"name":"Department of Medicine B, Sheba Medical Center, Tel Hashomer"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulla","family":"Watad","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel"},{"name":"Department of Medicine B, Sheba Medical Center, Tel Hashomer"},{"name":"Rheumatology Unit, Sheba Medical Center, Tel Hashomer, Israel"},{"name":"Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,8,9]]},"reference":[{"key":"2022050522160668200_keab633-B1","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3389\/fimmu.2018.02668","article-title":"The early phases of ankylosing spondylitis: emerging insights from clinical and basic science","volume":"9","author":"Watad","year":"2018","journal-title":"Front Immunol"},{"key":"2022050522160668200_keab633-B2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","article-title":"Ankylosing spondylitis: etiology, pathogenesis, and treatments","volume":"7","author":"Zhu","year":"2019","journal-title":"Bone Res"},{"key":"2022050522160668200_keab633-B3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/MAJ.0b013e318294457f","article-title":"The epidemiology of back pain, axial spondyloarthritis and HLA-B27 in the United States","volume":"345","author":"Reveille","year":"2013","journal-title":"Am J Med Sci"},{"key":"2022050522160668200_keab633-B4","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejim.2011.06.006","article-title":"Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications","volume":"22","author":"El Maghraoui","year":"2011","journal-title":"Eur J Intern Med"},{"key":"2022050522160668200_keab633-B5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D30P46V20Q","article-title":"Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature","volume":"18","author":"Girouard","year":"2012","journal-title":"Dermatol Online J"},{"key":"2022050522160668200_keab633-B6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/CLEP.S39981","article-title":"Systemic AA amyloidosis: epidemiology, diagnosis, and management","volume":"6","author":"Real de Asua","year":"2014","journal-title":"Clin Epidemiol"},{"key":"2022050522160668200_keab633-B7","first-page":"754","volume-title":"Dermatology","author":"Groves","year":"2017","edition":"4th edn."},{"key":"2022050522160668200_keab633-B8","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00296-012-2646-3","article-title":"Secondary amyloidosis in ankylosing spondylitis","volume":"33","author":"D\u00f6nmez","year":"2013","journal-title":"Rheumatol Int"},{"key":"2022050522160668200_keab633-B9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.4103\/1319-2442.229291","article-title":"Renal amyloidosis in ankylosing spondylitis: a monocentric study and review of literature","volume":"29","author":"Barbouch","year":"2018","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2022050522160668200_keab633-B10","first-page":"211","article-title":"Pathology of ankylosing spondylitis","volume":"10","author":"Cruickshank","year":"1960","journal-title":"Bull Rheum Dis"},{"key":"2022050522160668200_keab633-B11","first-page":"404","article-title":"Prevalence of selected chronic diseases in Israel","volume":"3","author":"Rennert","year":"2001","journal-title":"Isr Med Assoc J"},{"key":"2022050522160668200_keab633-B12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2022050522160668200_keab633-B13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","article-title":"Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2022050522160668200_keab633-B14","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1007\/s00296-012-2624-9","article-title":"Renal involvement in ankylosing spondylitis: prevalence, pathology, response to TNF-\u03b1 blocker","volume":"33","author":"Lee","year":"2013","journal-title":"Rheumatol Int"},{"key":"2022050522160668200_keab633-B15","first-page":"371","article-title":"Prevalence of subclinical amyloidosis in ankylosing spondylitis","volume":"34","author":"Singh","year":"2007","journal-title":"J Rheumatol"},{"key":"2022050522160668200_keab633-B16","first-page":"912","article-title":"Secondary amyloidosis in ankylosing spondylitis. A systematic survey of 137 patients using abdominal fat aspiration","volume":"24","author":"Gratacos","year":"1997","journal-title":"J Rheumatol"},{"key":"2022050522160668200_keab633-B17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/ard.52.3.174","article-title":"Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis","volume":"52","author":"Lehtinen","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"2022050522160668200_keab633-B18","first-page":"1334","article-title":"No improvement in survival of patients with amyloidosis associated with inflammatory rheumatic diseases \u2014 data from the Finnish national registry for kidney diseases","volume":"35","author":"Immonen","year":"2008","journal-title":"J Rheumatol"},{"key":"2022050522160668200_keab633-B19","first-page":"S16","article-title":"Mortality, course of disease and prognosis of patients with ankylosing spondylitis","volume":"20","author":"Braun","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"2022050522160668200_keab633-B20","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1681\/ASN.2006050460","article-title":"Amyloidosis-associated kidney disease","volume":"17","author":"Dember","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"2022050522160668200_keab633-B21","first-page":"644","article-title":"Outcome of 121 patients with renal amyloid A amyloidosis","volume":"19","author":"Ahbap","year":"2014","journal-title":"J Res Med Sci"},{"key":"2022050522160668200_keab633-B22","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/00062752-200001000-00012","article-title":"Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states","volume":"7","author":"Urieli-Shoval","year":"2000","journal-title":"Curr Opin Hematol"},{"key":"2022050522160668200_keab633-B23","doi-asserted-by":"crossref","first-page":"25781","DOI":"10.1074\/jbc.M001235200","article-title":"The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-\u03b1 through nuclear factor-\u03baB, and by 17\u03b2-estradiol through Sp-1 in human vascular endothelial cells","volume":"275","author":"Tanaka","year":"2000","journal-title":"J Biol Chem"},{"key":"2022050522160668200_keab633-B24","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/76216","article-title":"Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis","volume":"6","author":"Yan","year":"2000","journal-title":"Nat Med"},{"key":"2022050522160668200_keab633-B25","doi-asserted-by":"crossref","first-page":"e7859","DOI":"10.1097\/MD.0000000000007859","article-title":"Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: a STROBE-compliant observational study","volume":"96","author":"Esatoglu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2022050522160668200_keab633-B26","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.amjmed.2009.11.010","article-title":"Long-term TNF-\u03b1 blockade in patients with amyloid A amyloidosis complicating rheumatic diseases","volume":"123","author":"Fern\u00e1ndez-Nebro","year":"2010","journal-title":"Am J Med"},{"key":"2022050522160668200_keab633-B27","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/eurjhf\/hfr175","article-title":"Vitamin D deficiency is a predictor of reduced survival in patients with heart failure; vitamin D supplementation improves outcome","volume":"14","author":"Gotsman","year":"2012","journal-title":"Eur J Heart Fail"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keab633\/40495116\/keab633.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/5\/2072\/43562108\/keab633.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/5\/2072\/43562108\/keab633.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T22:25:25Z","timestamp":1651789525000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/5\/2072\/6346998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,9]]},"references-count":27,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,8,9]]},"published-print":{"date-parts":[[2022,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keab633","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5,1]]},"published":{"date-parts":[[2021,8,9]]}}}